Drilldown: Medicines
Appearance
Medicines > fda max
:
Indication-specific
or
~500 mg/d typical
& duration:
2-5 days after stopping (factor II resynthesis-limited) 
:
Indication-specific
or
~500 mg/d typical
& duration:
2-5 days after stopping (factor II resynthesis-limited) 
Use the filters below to narrow your results.
There are no results for this report.

